Human Genome Epidemiology Literature Finder
|
Records 1 - 19 (of 19 Records) |
| Query Trace: Arthritis and RFC1[original query] |
|---|
| ABCB1 C3435T polymorphism influences methotrexate sensitivity in rheumatoid arthritis patients. Clinical and experimental rheumatology 0 24 (5): 546-54. Takatori R, Takahashi K A, Tokunaga D, Hojo T, Fujioka M, Asano T, Hirata T, Kawahito Y, Satomi Y, Nishino H, Tanaka T, Hirota Y, Kubo |
| Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism. European journal of clinical pharmacology 2008 Nov 64 (11): 1057-68. Bohanec Grabar Petra, Logar Dusan, Lestan Boris, Dolzan Vi |
| Genetic polymorphisms in metabolic and cellular transport pathway of methotrexate impact clinical outcome of methotrexate monotherapy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2012 27 (2): 192-9. Kato Tomomi, Hamada Akinobu, Mori Shunsuke, Saito Hideyu |
| A single nucleotide polymorphism of reduced folate carrier 1 predicts methotrexate efficacy in Japanese patients with rheumatoid arthritis. Drug metabolism and pharmacokinetics 2013 28 (2): 164-8. Hayashi Hideki, Tazoe Yui, Tsuboi Seiji, Horino Masato, Morishita Mariko, Arai Teruhisa, Ohshima Motohiro, Matsuyama Taiji, Kosuge Kazuhiro, Yamada Hiroshi, Tsuji Daiki, Inoue Kazuyuki, Itoh Kunihi |
| Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis. Omics : a journal of integrative biology 2012 Nov 16 (11): 589-95. Plaza-Plaza José Cristian, Aguilera Margarita, Cañadas-Garre Marisa, Chemello Clarice, González-Utrilla Alfonso, Faus Dader María José, Calleja Miguel Ang |
| Role of methotrexate polyglutamation and reduced folate carrier 1 (RFC1) gene polymorphisms in clinical assessment indexes. Drug metabolism and pharmacokinetics 2013 28 (5): 442-5. Ando Yukie, Shimada Hideaki, Matsumoto Nozomi, Hirota Takeshi, Oribe Motohiro, Otsuka Eiji, Ishii Kohji, Morimoto Takuya, Ohashi Kyoichi, Ieiri Ichi |
| [Personalized drug therapy-directed clinical pharmacology research based on genetic polymorphisms and pharmacokinetics analysis]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 2013 133 (10): 1079-85. Hayashi Hide |
| Association of MDR1 C3435T and RFC1 G80A polymorphisms with methotrexate toxicity and response in Jordanian rheumatoid arthritis patients. International journal of clinical pharmacology and therapeutics 2014 Sep 52 (9): 746-55. Samara Sima A, Irshaid Yacoub M, Mustafa Khader |
| RFC1 80G>A is a genetic determinant of methotrexate efficacy in rheumatoid arthritis: a human genome epidemiologic review and meta-analysis of observational studies. Arthritis & rheumatology (Hoboken, N.J.) 2014 May 66 (5): 1111-20. Kung Tabitha N, Dennis Jessica, Ma Yiqing, Xie Gang, Bykerk Vivian, Pope Janet, Thorne Carter, Keystone Edward, Siminovitch Katherine A, Gagnon Fran |
| Methotrexate pharmacokinetic genetic variants are associated with outcome in rheumatoid arthritis patients. Pharmacogenomics 2015 Dec . Moya Patricia, Salazar Juliana, Arranz María Jesús, Díaz-Torné César, Del Río Elisabeth, Casademont Jordi, Corominas Hèctor, Baiget Montserr |
| Folate metabolic pathway single nucleotide polymorphisms: a predictive pharmacogenetic marker of methotrexate response in Indian (Asian) patients with rheumatoid arthritis. Pharmacogenomics 2015 Nov . Ghodke-Puranik Yogita, Puranik Amrutesh S, Shintre Pooja, Joshi Kalpana, Patwardhan Bhushan, Lamba Jatinder, Niewold Timothy B, Chopra Arvi |
| Preliminary study for predicting better methotrexate efficacy in Japanese patients with rheumatoid arthritis. Journal of pharmaceutical health care and sciences 2016 2 13. Hashiguchi Masayuki, Tsuru Tomomi, Miyawaki Kumika, Suzaki Midori, Hakamata Jun, Shimizu Mikiko, Irie Shin, Mochizuki Mayu |
| The association between reduced folate carrier-1 gene 80G/A polymorphism and methotrexate efficacy or methotrexate related-toxicity in rheumatoid arthritis: A meta-analysis. International immunopharmacology 2016 May 38 8-15. Li XiaoBing, Hu MingCai, Li WanPing, Gu Li, Chen MeiJuan, Ding HuiHua, Vanarsa Kamala, Du Yo |
| Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population. Journal of pharmaceutical health care and sciences 2016 2 35. Hashiguchi Masayuki, Shimizu Mikiko, Hakamata Jun, Tsuru Tomomi, Tanaka Takanori, Suzaki Midori, Miyawaki Kumika, Chiyoda Takeshi, Takeuchi Osamu, Hiratsuka Jiro, Irie Shin, Maruyama Junya, Mochizuki Mayu |
| MTRR A66G, RFC1 G80A, and MTHFR C677T and A1298C Polymorphisms and Disease Activity in Mexicans with Rheumatoid Arthritis Treated with Methotrexate. Genetic testing and molecular biomarkers 2017 Oct . González-Mercado Mirna Gisel, Rivas Fernando, Gallegos-Arreola M Patricia, Morán-Moguel M Cristina, Salazar-Páramo Mario, González-López Laura, Gámez-Nava J Iván, Muñoz-Valle J Francisco, Medina-Coss Y León Ricardo, González-Mercado Anahí, Aceves Mario A, Dávalos Nory O, Macías-Chumacera Agustín, Dávalos Ingrid |
| Do SNPs in folate pharmacokinetic pathway alter levels of intracellular methotrexate polyglutamates and affect response? A prospective study in Indian patients. Clinical rheumatology 2018 Jul . Sandhu Amit, Ahmad Shabeer, Kaur Jasbinder, Bhatnagar Archana, Dhawan Veena, Dhir Var |
| Association of MTHFR and RFC1 gene polymorphisms with methotrexate efficacy and toxicity in Chinese Han patients with rheumatoid arthritis. The Journal of international medical research 2019 10 48 (2): 300060519879588. Wang Shengli, Zuo Shuguang, Liu Zhigang, Ji Xinying, Yao Zhenqiang, Wang Xinch |
| Influence of RFC1 c.80A>G Polymorphism on Methotrexate-Mediated Toxicity and Therapeutic Efficacy in Rheumatoid Arthritis: A Meta-analysis. The Annals of pharmacotherapy 2021 Mar 10600280211002053. Naushad Shaik Mohammad, Alrokayan Salman A, Almajhdi Fahad N, Hussain Tajam |
| Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
- Page last reviewed:Feb 1, 2024
- Content source: